ObsEva (NASDAQ:OBSV) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued on Wednesday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

The business’s fifty day moving average price is $0.01 and its 200 day moving average price is $0.04. ObsEva has a one year low of $0.08 and a one year high of $2.14. The company has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.